Russell Microcap Index projected to add MTBC
June 13 2018 - 09:00AM
MTBC (NASDAQ: MTBC) (NASDAQ: MTBCP), a leading provider of
proprietary, cloud-based healthcare IT and revenue cycle management
solutions, announced today that FTSE Russell, which manages the
widely-followed Russell 2000® Index and other indices based on
market capitalization and style orientation, is expected to add
MTBC to the Russell Microcap® Index, effective June 25, according
to a preliminary list of additions posted June 8.
Membership in the Russell Microcap® Index means
automatic inclusion in the appropriate growth and value style
indexes. FTSE Russell determines membership for its Russell US
Indexes primarily by objective, market-capitalization rankings and
style attributes.
Russell US Indexes are widely used by investment
managers and institutional investors as the basis for index funds
and as benchmarks for active investment strategies. Approximately
$9 trillion in assets are benchmarked against Russell US Indexes.
Russell US Indexes are part of FTSE Russell, a leading global index
provider.
"We are very pleased to be considered by FTSE
Russell for inclusion in the Russell Microcap® Index," said Bill
Korn, Chief Financial Officer. "We expect that our addition to this
highly regarded index will help us further increase our visibility
with the investment community, especially with institutional
investors."
For more information on the Russell Microcap®
Index and the Russell US Indexes reconstitution, go to the "Russell
Reconstitution" section on the FTSE Russell website.
About MTBCMTBC is a healthcare
information technology company that provides a fully integrated
suite of proprietary web-based solutions, together with related
business services, to healthcare providers. Our integrated
Software-as-a-Service (or SaaS) platform helps our customers
increase revenues, streamline workflows and make better business
and clinical decisions, while reducing administrative burdens and
operating costs. MTBC's common stock trades on the NASDAQ Capital
Market under the ticker symbol "MTBC," and its Series A Preferred
Stock trades on the NASDAQ Capital Market under the ticker symbol
"MTBCP."
For additional information, please visit our
website at www.mtbc.com.
About FTSE Russell
FTSE Russell is a leading global index provider
creating and managing a wide range of indexes, data and analytic
solutions to meet client needs across asset classes, style and
strategies. Covering 98% of the investable market, FTSE Russell
indexes offer a true picture of global markets, combined with the
specialist knowledge gained from developing local benchmarks around
the world.
FTSE Russell index expertise and products are
used extensively by institutional and retail investors globally.
Approximately $16.2 trillion is currently benchmarked to FTSE
Russell indexes. For over 30 years, leading asset owners, asset
managers, ETF providers and investment banks have chosen FTSE
Russell indexes to benchmark their investment performance and
create investment funds, ETFs, structured products and index-based
derivatives. FTSE Russell indexes also provide clients with tools
for asset allocation, investment strategy analysis and risk
management.
A core set of universal principles guides FTSE
Russell index design and management: a transparent rules-based
methodology is informed by independent committees of leading market
participants. FTSE Russell is focused on index innovation and
customer partnership applying the highest industry standards and
embracing the IOSCO Principles. FTSE Russell is wholly owned by
London Stock Exchange Group.
For more information, visit
www.ftserussell.com.
Follow MTBC
on Twitter, LinkedIn and Facebook.
SOURCE MTBC
Company Contact:Rachel GrossingerMarketing
ManagerMedical Transcription Billing,
Corp.rgrossinger@mtbc.com732-873-5133
Investor Contact:Bill KornChief Financial
OfficerMedical Transcription Billing,
Corp.bkorn@mtbc.com732-873-5133
CareCloud (NASDAQ:MTBC)
Historical Stock Chart
From Feb 2024 to Mar 2024
CareCloud (NASDAQ:MTBC)
Historical Stock Chart
From Mar 2023 to Mar 2024